Compliance of pediatric and adolescent cancer patients
β Scribed by Cameron K. Tebbi; K. Michael Cummings; Michael A. Zevon; Leasel Smith; Mary Richards; Janis Mallon
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 630 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Compliance with self-administered therapy in pediatric and adolescent patients is not always complete
π SIMILAR VOLUMES
Supplement based on the proceedings of a satellite symposium at SIOP 2000 in Amsterdam (''Anemia in Pediatric Cancer Patients-How to Manage It?''), and also on the pediatric session of a stand-alone symposium held in Seville, Spain in 2000 (''Evolving Issues in Oncology: What is the 'Optimal' Hemogl
## Abstract ## Background Children with cancer frequently develop anemia both from the disease and from chemoβ and radiotherapy. Considered a manageable complication, anemia is often not treated until it becomes severe, i.e., hemoglobin (Hb) level β€β7 g/dL. The most frequent treatment employed for
Twenty-four pediatric patients with acute lymphoblastic leukemia (ALL) on maintenance therapy were evaluated for their compliance with taking their prescribed doses of oral mercaptopurine (6-MP). Procedure and Results. We utilized the Medication Event Monitoring System (MEMS; Aprex Corporation, Fre
## Background: Pulmonary disease in the pediatric cancer patient continues to pose a difficult clinical dilemma. bronchoalveolar lavage (bal) is commonly utilized for the diagnosis of pulmonary complications in the immunocompromised child. ## Procedure: We retrospectively reviewed 53 bal procedur
## Abstract Avascular femoral head necrosis was identified in 15 patients treated at a major pediatric oncology center from 1974 to 1991. The predominant underlying diagnosis was acute leukemia (lymphoblastic, __n__ = 6; nonβlymphoblastic, __n__ = 2); two patients had chronic myeloid leukemia, two